<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Hansjo</forename><surname>¨rg Baurecht</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Melanie</forename><surname>Hotze</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Brand</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine II -Grosshadern</orgName>
								<orgName type="institution">Ludwig-Maximilians-University (LMU)</orgName>
								<address>
									<postCode>81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Bu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Gastroenterology, Hepatology and Endocri-nology</orgName>
								<address>
									<addrLine>Campus Mitte</addrLine>
									<postCode>10117</postCode>
									<settlement>Charite ´, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><surname>Cormican</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychiatry and Institute of Molecular Medicine</orgName>
								<orgName type="laboratory">Neuropsychiatric Genetics Research Group</orgName>
								<orgName type="institution">Trinity College Dublin</orgName>
								<address>
									<addrLine>Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aiden</forename><surname>Corvin</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychiatry and Institute of Molecular Medicine</orgName>
								<orgName type="laboratory">Neuropsychiatric Genetics Research Group</orgName>
								<orgName type="institution">Trinity College Dublin</orgName>
								<address>
									<addrLine>Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Ellinghaus</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Clinical Molecular Biology</orgName>
								<orgName type="institution">Christian-Albrechts-University of Kiel</orgName>
								<address>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eva</forename><surname>Ellinghaus</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Clinical Molecular Biology</orgName>
								<orgName type="institution">Christian-Albrechts-University of Kiel</orgName>
								<address>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jorge</forename><surname>Esparza-Gordillo</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Max-Delbru ¨ck-Centrum (MDC) for Molecular Medicine</orgName>
								<address>
									<postCode>13092</postCode>
									<settlement>Berlin-Buch, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Experimental and Clinical Research Cen-ter</orgName>
								<orgName type="laboratory">Pediatric Allergy</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Charite ´Universita ¨tsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Regina</forename><surname>Fo ¨lster-Holst</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andre</forename><surname>Franke</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Clinical Molecular Biology</orgName>
								<orgName type="institution">Christian-Albrechts-University of Kiel</orgName>
								<address>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Gieger</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Genetic Epidemiology</orgName>
								<orgName type="institution">German Research Cen-ter for Environmental Health</orgName>
								<address>
									<addrLine>Helmholtz Zentrum Mu ¨nchen</addrLine>
									<postCode>85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution">Helmholtz Zentrum Mu ¨nchen -German Research Center for Environmental Health</orgName>
								<address>
									<postCode>85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norbert</forename><surname>Hubner</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Max-Delbru ¨ck-Centrum (MDC) for Molecular Medicine</orgName>
								<address>
									<postCode>13092</postCode>
									<settlement>Berlin-Buch, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Illig</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Hannover Medical School</orgName>
								<orgName type="institution">Hannover Unified Biobank</orgName>
								<address>
									<postCode>30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alan</forename><forename type="middle">D</forename><surname>Irvine</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Psoriasis Association Genetics Extension</orgName>
								<address>
									<addrLine>Stefan Schreiber, 5</addrLine>
									<postCode>23</postCode>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department">Department of Paediatric Derma-tology</orgName>
								<orgName type="institution">Our Lady&apos;s Children&apos;s Hospital</orgName>
								<address>
									<addrLine>Dublin 12</addrLine>
									<settlement>Crumlin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="institution">National Children&apos;s Research Centre</orgName>
								<address>
									<addrLine>Dublin 12</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff14">
								<orgName type="department">Department of Clinical Medicine</orgName>
								<orgName type="institution">Trinity College Dublin</orgName>
								<address>
									<addrLine>Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Kabesch</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Pediatric Pneumology and Allergy</orgName>
								<orgName type="institution">University Children&apos;s Hospital Regensburg (KUNO)</orgName>
								<address>
									<postCode>93042</postCode>
									<settlement>Regensburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Young</forename><forename type="middle">A E</forename><surname>Lee</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Max-Delbru ¨ck-Centrum (MDC) for Molecular Medicine</orgName>
								<address>
									<postCode>13092</postCode>
									<settlement>Berlin-Buch, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Experimental and Clinical Research Cen-ter</orgName>
								<orgName type="laboratory">Pediatric Allergy</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Charite ´Universita ¨tsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfgang</forename><surname>Lieb</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Institute of Epidemiology and PopGen Biobank</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ingo</forename><surname>Marenholz</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Max-Delbru ¨ck-Centrum (MDC) for Molecular Medicine</orgName>
								<address>
									<postCode>13092</postCode>
									<settlement>Berlin-Buch, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Experimental and Clinical Research Cen-ter</orgName>
								<orgName type="laboratory">Pediatric Allergy</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Charite ´Universita ¨tsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">H Irwin</forename><surname>Mclean</surname></persName>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Dermatology and Genetic Medicine</orgName>
								<orgName type="department" key="dep2">College of Life Sciences and College of Medicine</orgName>
								<orgName type="department" key="dep3">Dentistry &amp; Nursing</orgName>
								<orgName type="institution">University of Dundee</orgName>
								<address>
									<postCode>DD1 5EH</postCode>
									<settlement>Dundee</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Derek</forename><forename type="middle">W</forename><surname>Morris</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychiatry and Institute of Molecular Medicine</orgName>
								<orgName type="laboratory">Neuropsychiatric Genetics Research Group</orgName>
								<orgName type="institution">Trinity College Dublin</orgName>
								<address>
									<addrLine>Dublin 2</addrLine>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">School of Psychology and Discipline of Biochemistry</orgName>
								<orgName type="laboratory">Cognitive Genetics and Therapy Group</orgName>
								<orgName type="institution">National University of Ireland</orgName>
								<address>
									<settlement>Galway</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrich</forename><surname>Mrowietz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rajan</forename><surname>Nair</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<postCode>48109-5675</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><forename type="middle">M</forename><surname>No</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<postCode>53127</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department">Department of Genomics, Life &amp; Brain Center</orgName>
								<orgName type="institution">University of Bonn</orgName>
								<address>
									<postCode>53127</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalija</forename><surname>Novak</surname></persName>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Department of Dermatology and Allergy</orgName>
								<orgName type="department" key="dep2">23 Department of Internal Medicine</orgName>
								<orgName type="institution">University of Bonn Medical Center</orgName>
								<address>
									<postCode>53105</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="institution">University Medical Center Schleswig-Holstein</orgName>
								<address>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Grainne</forename><forename type="middle">M</forename><surname>O'regan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Catherine</forename><surname>Smith</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Division of Genetics and Molecular Medicine</orgName>
								<orgName type="institution" key="instit1">St John&apos;s Institute of Dermatology</orgName>
								<orgName type="institution" key="instit2">Kings College London</orgName>
								<address>
									<postCode>SE1 9RT</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Konstantin</forename><surname>Strauch</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Genetic Epidemiology</orgName>
								<orgName type="institution">German Research Cen-ter for Environmental Health</orgName>
								<address>
									<addrLine>Helmholtz Zentrum Mu ¨nchen</addrLine>
									<postCode>85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department" key="dep1">Institute of Medical Informatics</orgName>
								<orgName type="department" key="dep2">Biometry and Epidemiology</orgName>
								<orgName type="department" key="dep3">Chair of Genetic Epidemiology</orgName>
								<orgName type="institution">Ludwig-Maximilians-Universita ¨t</orgName>
								<address>
									<postCode>80539</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philip</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<postCode>48109-5675</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Richard</forename><surname>Trembath</surname></persName>
							<affiliation key="aff26">
								<orgName type="department">Barts and the London School of Medicine and Dentistry</orgName>
								<orgName type="institution">Queen Mary University of London</orgName>
								<address>
									<postCode>E1 4NS</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lam</forename><forename type="middle">C</forename><surname>Tsoi</surname></persName>
							<affiliation key="aff27">
								<orgName type="department" key="dep1">Department of Biostatistics</orgName>
								<orgName type="department" key="dep2">Center for Sta-tistical Genetics</orgName>
								<orgName type="department" key="dep3">School of Public Health</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<postCode>48109-5314</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Weichenthal</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jonathan</forename><surname>Barker</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Division of Genetics and Molecular Medicine</orgName>
								<orgName type="institution" key="instit1">St John&apos;s Institute of Dermatology</orgName>
								<orgName type="institution" key="instit2">Kings College London</orgName>
								<address>
									<postCode>SE1 9RT</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">James</forename><forename type="middle">T</forename><surname>Elder</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<postCode>48109-5675</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff28">
								<orgName type="institution">Ann Arbor Veterans Affairs Hospital</orgName>
								<address>
									<postCode>48105</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Weidinger</surname></persName>
							<email>sweidinger@dermatology.uni-kiel.de</email>
							<affiliation key="aff1">
								<orgName type="department">Department of Dermatology, Allergology, and Venereology</orgName>
								<orgName type="institution">University Hospital Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
									<postCode>24105</postCode>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heather</forename><forename type="middle">J</forename><surname>Cordell</surname></persName>
							<affiliation key="aff29">
								<orgName type="department">Institute of Genetic Medicine</orgName>
								<orgName type="institution">Newcastle University</orgName>
								<address>
									<postCode>NE1 3BZ</postCode>
									<settlement>Newcastle upon Tyne</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
							<email>s.j.brown@dundee.ac.uk</email>
							<affiliation key="aff30">
								<orgName type="department" key="dep1">Dermatology and Genetic Medicine</orgName>
								<orgName type="department" key="dep2">Medical School</orgName>
								<orgName type="institution" key="instit1">Medical Research Institute</orgName>
								<orgName type="institution" key="instit2">Ninewells Hospital</orgName>
								<orgName type="institution" key="instit3">University of Dundee</orgName>
								<address>
									<postCode>DD1 9SY</postCode>
									<settlement>Dundee</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">B6CB552413DC28DC9F977347A82C5E34</idno>
					<idno type="DOI">10.1016/j.ajhg.2014.12.004</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Atopic dermatitis and psoriasis are the two most common immune-mediated inflammatory disorders affecting the skin.</s><s>Genome-wide studies demonstrate a high degree of genetic overlap, but these diseases have mutually exclusive clinical phenotypes and opposing immune mechanisms.</s><s>Despite their prevalence, atopic dermatitis and psoriasis very rarely co-occur within one individual.</s><s>By utilizing genome-wide association study and ImmunoChip data from &gt;19,000 individuals and methodologies developed from meta-analysis, we have identified opposing risk alleles at shared loci as well as independent disease-specific loci within the epidermal differentiation complex (chromosome 1q21.3), the Th2 locus control region (chromosome 5q31.1), and the major histocompatibility complex (chromosome 6p21-22).</s><s>We further identified previously unreported pleiotropic alleles with opposing effects on atopic dermatitis and psoriasis risk in PRKRA and ANXA6/TNIP1.</s><s>In contrast, there was no evidence for shared loci with effects operating in the same direction on both diseases.</s><s>Our results show that atopic dermatitis and psoriasis have distinct genetic mechanisms with opposing effects in shared pathways influencing epidermal differentiation and immune response.</s><s>The statistical analysis methods developed in the conduct of this study have produced additional insight from previously published data sets.</s><s>The approach is likely to be applicable to the investigation of the genetic basis of other complex traits with overlapping and distinct clinical features.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Atopic dermatitis (AD, synonymous with eczema [MIM 603165]) and psoriasis (psoriasis vulgaris [MIM 177900]) are the two most common chronic inflammatory skin con-ditions.</s><s>They are associated with a significantly reduced quality of life and multiple comorbidities. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>Both diseases result from the interaction of genetic and environmental factors and are characterized by epidermal defects as well as local and systemic immunological abnormalities.</s></p><p><s>Despite a lifetime prevalence of ~2% for psoriasis and 10%-20% for AD, <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> these diseases rarely co-occur within an individual <ref type="bibr" target="#b4">5</ref> -an observation attributed to opposing immune response patterns. <ref type="bibr" target="#b5">6</ref></s><s>However, it has been reported that both Th1-cell-dominated autoimmune and Th2-celldominated allergic diseases aggregate within families <ref type="bibr" target="#b6">7</ref> and that parental psoriasis might increase the risk of AD in offspring. <ref type="bibr" target="#b7">8</ref></s><s>Furthermore, genome-wide linkage and association studies have shown genetic risk loci in each disease that map to similar regions of the genome.</s><s>The epidermal differentiation complex (EDC) on chromosome 1q21.3</s><s>]<ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> Null mutations in the gene encoding filaggrin (FLG [MIM 135940]) represent the strongest known risk factor for AD <ref type="bibr" target="#b13">13,</ref><ref type="bibr" target="#b14">14</ref> and account for at least a proportion of AD risk within the EDC, but FLG-null mutations are not associated with psoriasis. <ref type="bibr" target="#b15">15,</ref><ref type="bibr" target="#b16">16</ref></s><s>A deletion of the late cornified envelope genes LCE3B-LCE3C (MIM 612614, 612615) represents a genetic substrate for psoriasis within the EDC, <ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b18">18</ref> but this deletion is not associated with AD. <ref type="bibr" target="#b19">19</ref> The cytokine cluster encoded at 5q23.1-5q31.1 includes variants showing association with both diseases, <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">20,</ref><ref type="bibr" target="#b21">21</ref> and an intergenic region of chromosome 20q13.2</s><s>has also shown association with both AD and psoriasis. <ref type="bibr" target="#b23">22,</ref><ref type="bibr" target="#b24">23</ref></s><s>Finally, a recent genome-wide association study (GWAS) on AD identified a strong association within the margins of the major histocompatibility complex (MHC) <ref type="bibr" target="#b20">20</ref> on chromosome 6p21.3,</s><s>less than 2.4 kb from a variant associated with HLA-Cw6 (MIM 142840), <ref type="bibr" target="#b25">24</ref> the strongest known psoriasis-risk locus.</s></p><p><s>In order to gain insight into overlapping and specific genetic mechanisms, we systematically compared and contrasted AD and psoriasis via analytical techniques developed from meta-analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subjects and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Subjects</head><p><s>Genome-wide genotype data were obtained on samples from six case-control cohorts (three each of AD and psoriasis), totaling 2,262 AD and 4,489 psoriasis case subjects and 12,333 control subjects (Table <ref type="table" target="#tab_1">S1</ref> available online).</s></p><p><s>The German AD case subjects were recruited from tertiary dermatology clinics at Munich, as part of the GENEVA study, University of Kiel, University of Bonn, and the University Children's Hospital of Charite ´Universita ¨tsmedizin Berlin.</s><s>AD was diagnosed by experienced dermatologists and/or pediatricians according to the UK Diagnostic Criteria. <ref type="bibr" target="#b26">25</ref></s><s>German control subjects were obtained from the PopGen biorepository, <ref type="bibr" target="#b27">26</ref> the population-based KORA study in southern Germany, <ref type="bibr" target="#b28">27</ref> and the German part of ISAAC II to assess the prevalence of asthma and allergies in schoolchildren. <ref type="bibr" target="#b29">28</ref></s><s>The Irish AD case collection was recruited from the secondary and tertiary pediatric dermatology clinic at Our Lady's Children's Hospital, Crumlin, Dublin.</s><s>Irish control individuals were obtained from healthy adult blood donors as part of the Trinity Biobank, Dublin. <ref type="bibr" target="#b30">29</ref></s><s>he German psoriasis case subjects were recruited from the tertiary dermatology clinic at the University of Kiel and German controls were again obtained from the PopGen biorepository and the KORA study (independent from those used as controls for AD).</s><s>The British psoriasis case-control study is part of the Welcome Trust Case Control Consortium 2 <ref type="bibr" target="#b25">24</ref> and the US psoriasis study has been described elsewhere. <ref type="bibr" target="#b21">21</ref></s><s>mmunoChip data on 2,425 AD case subjects, 3,580 psoriasis case subjects, and 9,061 control subjects were obtained from previous studies, <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> including data on a subset of case and control individuals also analyzed by GWAS.</s><s>Results of analysis of the four most prevalent FLG (RefSeq accession number NM_002016.1)</s><s>loss-of-function mutations were obtained for a total of 2,865 case subjects and 5,540 control subjects as data generated for previous studies; <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b20">20</ref> the FLG mutations in these analyses are as follows: p.Arg501* (c.1501C&gt;T), p.Ser761Cysfs*36 (c.2282_2285del), p.Arg2447* (c.7339C&gt;T), and p.Ser3247* (c.9740C&gt;A) (R501X, 2282del4, R2447X, and S3247X, respectively).</s></p><p><s>The institutional review board in each contributing center approved these studies.</s><s>All participants (or their parents or guardians) gave written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design</head><p><s>The study design is summarized in Figure <ref type="figure">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quality Control</head><p><s>Quality control and standard GWAS analysis of genotyped singlenucleotide variants (SNVs) was carried out with PLINK <ref type="bibr" target="#b31">30</ref> and R. Samples with extensive missing data (rate &gt;5%), excess of heterozygosity or homozygosity, and discrepant gender determined on the basis of average X-chromosomal heterozygosity compared to the gender recorded in the database were excluded.</s><s>We then examined identity-by-state (IBS) sharing and estimated identity-bydecent (IBD) on a pruned SNV set between all pairs of individuals and deleted resulting duplicates or closely related samples with PI_HAT &gt; 0.1875 (halfway between expected IBD for third-and second-degree relatives).</s><s>Multidimensional scaling (MDS) of the pairwise IBS matrix was carried out to identify and delete outliers of unusual ancestry and to calculate genome-wide principalcomponent scores for each individual.</s><s>We excluded 894 samples because of SNVs showing a missing rate of &gt;5%, deviation of Hardy-Weinberg equilibrium p HWE &lt; 10 À8 , or minor allele frequency (MAF) &lt;5% (summarized in Table <ref type="table" target="#tab_2">S2</ref>).</s><s>After quality control, the resulting SNVs and samples were analyzed for association via logistic regression with age, sex, and principal-component scores as covariates.</s><s>Results from each panel were investigated to determine whether established GWAS loci were identified for the respective trait of interest, and genomic control inflation factors were calculated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Imputation of SNVs and Classical HLA Alleles</head><p><s>Any SNVs showing significant association were checked (e.g., by visual inspection of the intensity cluster plots and investigation of consistency of LD with surrounding markers) and those SNVs deemed unreliable were removed.</s><s>The final data sets of high-quality SNVs were prephased with SHAPEIT <ref type="bibr" target="#b32">31</ref> and subsequently used to perform imputation with IMPUTE2, <ref type="bibr" target="#b33">32</ref> the 1000 Genomes reference panel (integrated variant set, release March 2012). <ref type="bibr" target="#b34">33</ref></s><s>In the Irish AD collection (Table <ref type="table" target="#tab_1">S1</ref>), case and control subjects were genotyped on different platforms, and therefore only the 131,692 SNVs in common between the platforms were used to inform imputation.</s></p><p><s>Postimputation SNVs with low imputation quality (info score &lt; 0.4), call rate &lt;95%, deviation from p HWE &lt; 10 À8 , or MAF &lt; 5% were excluded.</s><s>A final data set of approximately 5.2 million SNVs in 2,079 AD case subjects, 3,867 control subjects, 4,212 psoriasis case subjects, and 8,032 control subjects were eligible for subsequent analysis (Table <ref type="table" target="#tab_3">S3</ref>).</s></p><p><s>Classical alleles for HLA-A, HLA-B, and HLA-C were imputed for each case-control cohort separately by HLA*IMP <ref type="bibr" target="#b36">34,</ref><ref type="bibr" target="#b37">35</ref> and best guess genotypes with probability &gt;0.9.</s><s>Additional classical HLA-DQA1, HLA-DQB1, and HLA-DRB1 alleles were imputed in each case-control cohort with the exception of the Irish samples, in which there were insufficient informative SNPs.</s><s>Alleles with a frequency &gt;1% were put forward for analysis.</s><s>For each individual, alleles were coded as having no, one, or two copies of the respective allele via allele probability &gt;0.9.</s><s>We obtained high-quality data at the four-digit level with call rates of 92%-100% and accuracy of 92%-98%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Meta-GWAS was performed on each disease, via standard methodologies.</s><s>To analyze these findings further, we developed two different meta-analysis-based approaches to filter SNVs and model the contrasting effects in each disease.</s><s>The first was a compare and contrast meta-analysis (CCMA) approach inspired by a subsetbased method. <ref type="bibr" target="#b38">36</ref></s><s>The second used transethnic meta-analysis implemented in the MANTRA software, <ref type="bibr" target="#b39">37</ref> combining all six studies by using prior clustering to reflect the ethnic difference and the disease type.</s><s>The MHC region was reserved for separate analysis because of its unique and complex variability and patterns of strong linkage disequilibrium (LD).</s></p><p><s>The CCMA approach is based on an adaptation of an idea of Bhattacharjee et al., <ref type="bibr" target="#b38">36</ref> who modeled association with heterogeneous traits.</s><s>With METAL, <ref type="bibr" target="#b40">38</ref> we calculated z-scores signed positive or negative with respect to the same reference allele for two metaanalyses, T 1 , combining AD studies only, and T 2 , combining psoriasis studies only.</s><s>We then calculated the overall test statistic T max with the formula T max ¼ maxðjT 1 j; jT 2 j; jT 12shared j;</s></p><formula xml:id="formula_0">T 12opposing Þ,</formula><p><s>where</s></p><formula xml:id="formula_1">T 12shared ¼ ðT 1 þ T 2 Þ= ffiffiffi 2 p and T 12opposing ¼ ðT 1 À T 2 Þ= ffiffiffi 2 p</formula><p><s>. We categorized the effect of each SNV as corresponding to an effect Figure <ref type="figure">1</ref>.</s><s>Study Design Abbreviations are as follows: CCMA, case control meta-analysis; MANTRA, metaanalysis of trans-ethnic association studies; BFD, Bayesian false discovery; PO, prior odds; *conditional analysis for the MHC was also carried out with imputed classical HLA-allele (detailed in the Subjects and Methods).</s><s>on AD only, to an effect on psoriasis only, to a shared effect (in the same direction on AD and psoriasis), or to opposing effects, according to which of the four test statistics ðjT 1 j; jT 2 j; jT 12shared j;</s></p><formula xml:id="formula_2">T 12opposing</formula><p><s>Þ was the largest.</s><s>In order to derive a p value for T max , we worked out an empirical null distribution by simulating 10,000,000 realizations of two normally distributed random variables, Z 1 and Z 2 .</s><s>Then we calculated</s></p><formula xml:id="formula_3">Z 12shared ¼ ðZ 1 þ Z 2 Þ= ffiffiffi 2 p , Z 12opposing ¼ ðZ 1 À Z 2 Þ= ffiffiffi 2 p ,<label>and</label></formula><formula xml:id="formula_4">Z max ¼ maxðjZ 1 j; jZ 2 j; jZ 12shared j; Z 12opposing</formula><p><s>Þ.</s><s>The emprical p values can be derived as</s></p><formula xml:id="formula_5">P emp ¼ ð#ðZ max &gt; T max Þ þ 1Þ=ð# simulations þ 1Þ.</formula><p><s>In a separate simulation of 1,000,000,000 replicates, we derived a calibration curve for the p values and found it suitable up to a p value of 10 À9 .</s><s>Hence with the calibration curve we can derive Z max thresholds corresponding to standard genome-wide ''suggestive'' <ref type="bibr">(10 À5</ref> ) and genome-wide ''significant'' (10 À8 ) thresholds, corresponding to T max values of approximately 4.7 and 6.0, respectively (Figure <ref type="figure">S1</ref>).</s></p><p><s>In the second approach we used the MANTRA software <ref type="bibr" target="#b39">37</ref> developed for transethnic meta-analysis.</s><s>MANTRA uses a Bayesian partition model for grouping studies according to their ethnicity.</s><s>We adopted this idea and worked out a prior distribution to cluster studies according to both our phenotypes of interest and the genetic distance between the studies derived from our MDS analysis based on the pairwise IBS matrix: D Total ¼ D Disease þ D Ethnicity , where D Ethnicity is a diagonal matrix of Euclidean distances between study centers.</s><s>To distinguish the two diseases (psoriasis and AD), we set the corresponding cells of the D Disease matrix to D ij ¼ 2 3 max(D Ethnicity ) and to account for the different subphenotype in AD (AD in general versus childhood AD), we set the corresponding cells of the D Disease matrix to D ij ¼ max(D Ethnicity ), resulting in the prior components shown in Table <ref type="table">S4</ref>.</s></p><p><s>We calibrated the resulting log 10 BF MANTRA ¼ log 10 (Bayes Factors) from the MANTRA software in order to find a threshold for filtering SNVs, which were compared with the CCMA top SNVs and subsequently carried forward to multinomial regression modeling.</s><s>To perform this calibration, we calculated the Bayesian False Discovery Probability proposed by Wakefield <ref type="bibr" target="#b41">39</ref> with diverse prior odds (PO) in favor of H 0 :</s></p><formula xml:id="formula_6">BFDP ¼ BF MANTRA 3 PO 1 þ BF MANTRA 3 PO :</formula><p><s>Sensitivity analysis was performed with only the D Ethnicity as prior matrix and we observe high correlation (r 2 &gt; 0.99) of the topranked SNVs (BFDP &lt; 0.05; PO ¼ 99) with our analysis (data not shown).</s></p><p><s>Finally, we carried forward a filtered set of SNVs from CCMA and MANTRA for modeling via a multinomial regression model, adjusted for sex and the first four genome-wide principal-component scores.</s><s>The multinomial model involves three outcome categories: the ''baseline'' category into which all controls are categorized, a ''psoriasis'' case category, and an ''AD'' case category (modeled through regression coefficients b PSO and b AD , respectively).</s><s>This analysis makes use of individual-level genotypes and is thus more computationally intensive (although arguably more powerful and more statistically satisfactory) than CCMA and MANTRA.</s><s>We calculated p values for tests that were designed to be sensitive to the following situations: an overall SNV effect (on either or both diseases, in either direction), an individual SNV effect on one disease (but not on the other), a shared SNV effect (operating in the same direction for both diseases), and a contrasting SNV effect (operating in opposing directions between both diseases), by performing Wald tests of the following linear hypotheses:</s></p><formula xml:id="formula_7">Overall effect : H 0 : b PSO þ b AD b PSO À b AD ¼ 0 0 ; H 1 : b PSO þ b AD b PSO À b AD s 0 0 Psoriasis effect : H 0 : b PSO ¼ 0; H 1 : b PSO s0 AD effect : H 0 : b AD ¼ 0; H 1 : b AD s0 Shared effect : H 0 : b PSO þ b AD ¼ 0; H 1 : b PSO þ b AD s0</formula><p><s>Opposing effect :</s></p><formula xml:id="formula_8">H 0 : b PSO À b AD ¼ 0; H 1 : b PSO À b AD s0</formula><p><s>The overall significance of the SNV was assessed through the 2 degree of freedom (df) test of overall effect, which compares the null hypothesis that the SNV has no effect on either psoriasis or AD with the alternative hypothesis that it has an effect on one or both diseases.</s><s>The other four 1 df tests were used to categorize the effect (in analogy to CCMA) in four categories-AD only, psoriasis only, shared effect, and opposing effects-by categorizing according to the minimum of the p values: p MNM ¼ min(p AD , p PSO , p SHARED , p OPPOSING ).</s><s>The rationale for the use of the minimum of these 1 df tests for categorization is as follows: if a SNV is associated with one disease but not the other, the test of a nonzero regression coefficient for that disease (even while unnecessarily also allowing for a nonzero coefficient for the other disease, as is done in the psoriasis effect and AD effect tests), should be more powerful than a test that erroneously groups together the coefficients of the associated and the nonassociated disease (as is done in the shared and opposing effect tests).</s><s>This is on account of the fact that grouping together these coefficients will incur a penalty in terms of increasing the variance, while not incurring any greater expected magnitude of effect since the expected value of the regression coefficient for the nonassociated disease is zero.</s><s>If, on the other hand, the SNV has effects that operate in the same direction on both diseases, then a test based on adding together these effects (as is done in the shared effect test) should be more powerful than considering each effect on its own, or subtracting one effect from the other (as is done in the opposing effect test), because adding together the coefficients induces the greatest magnitude of effect.</s><s>Finally, if the SNV has effects that operate in opposite directions in the two diseases, then a test based on subtracting one effect from the other (as is done in the opposing effect test) should be most powerful because it induces the greatest magnitude of effect.</s></p><p><s>All analyses if not explicitly stated were carried out with R. For the purposes of this analysis, we distinguished between a shared genetic ''region'' and a shared genetic ''locus.''</s><s>We arbitrarily designated a shared region as a block of genomic DNA spanning 2 Mb with association signals for both traits.</s><s>We defined a genetic locus as the lead SNV and all SNVs with r 2 &gt; 0.5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Predicted Protein Network Analysis and Gene Ontology Analysis</head><p><s>Functional protein association networks were investigated in silico and gene ontology analyses were performed with STRING 9.1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Filtering Variants to Define Risk Effects Quality control and imputation generated 5.2 million SNVs with a minor allele frequency &gt;0.01 for further analysis (Figure <ref type="figure">1</ref>).</s><s>GWASs within each cohort resulted in genomic inflation factors l between 1.03 and 1.08.</s><s>Meta-GWAS performed on each disease confirmed previously reported risk loci in AD and psoriasis and illustrated areas of colocalization on chromosomes 1, 5, and 6 (Figure <ref type="figure" target="#fig_1">2A</ref>).</s></p><p><s>Excluding the MHC, 2,210 SNVs were identified with shared (by which we mean alleles having effects operating in the same direction in both diseases), opposing, and disease-specific SNVs with CCMA test statistic T max &gt; 4.7.</s><s>This threshold was defined to correspond to a suggestive significance of p &lt; 10 À5 in order to reduce the probability of false negatives.</s><s>The 2,210 SNVs were condensed to 142 distinct loci after an LD-based clumping procedure <ref type="bibr" target="#b31">30</ref> with the following parameters: distance % 250 kb and r 2 R 0.5.</s></p><p><s>Analysis with MANTRA revealed 3,304 SNVs with Bayesian false discovery probability (BFDP) &lt; 0.05 with prior odds (PO) 1/99 resulting in 76 distinct loci after clumping.</s><s>The overlap of CCMA and MANTRA gave 2,183 SNVs and the union of both methods resulted in 3,331 SNVs that were carried forward for multinomial regression modeling (MNM), which was adjusted for sex and the first four genome-wide principal-component scores.</s><s>The results are displayed in Figure <ref type="figure" target="#fig_1">2B</ref>, in which disease-specific, shared, and opposing loci are coded by color.</s><s>SNVs showing genome-wide significance in at least one of the three methods of analysis (T max &gt; 6, BFDP &lt; 0.05 with PO ¼ 1/999, or p MNM &lt; 10 À8 ) map to 144 distinct loci (Table <ref type="table">S5</ref>).</s><s>Comparison of effect classification (AD, psoriasis, shared, opposing) in CCMA and MNM (Figure <ref type="figure" target="#fig_1">S2</ref>) showed an agreement of 94.8% when excluding the MHC region (Figure <ref type="figure">S3</ref>).</s><s>For further investigation, we considered only loci containing more than one SNV and an effect classified in the same direction by CCMA and MNM.</s></p><p><s>Validation of Previously Reported AD-and Psoriasis-Risk Loci 15 European and 9 Asian loci have previously been reported in GWASs on AD, and 44 European and 9 Asian loci have been reported in association with psoriasis (Table <ref type="table">S6</ref>).</s><s>In our disease-specific meta-analysis individuals of white European descent, 14 of the European AD loci as well as 43 of the psoriasis loci are replicated.</s><s>Furthermore, 4 AD and 4 psoriasis loci so far reported only in Asians showed evidence for association in European populations (p &lt; 10  <ref type="table">S6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>New Opposing-Effect Loci Identified by Genome-wide Comparative Analysis</head><p><s>Excluding the MHC, 25 loci showed a genome-wide significant association with either skin disorder, defined by all three methods of analysis (CCMA T max &gt; 6 and MANTRA BFDP &lt; 0.05 with PO ¼ 1/999, and p MNM &lt; 10 À8 ) including six loci that were coassociated with both AD and psoriasis.</s><s>Each coassociated locus displayed opposing effects and two of these loci (2q31.2,</s><s>5q33.1)</s><s>have not previously been reported as showing coassociation with AD and psoriasis (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>2q31.2 demonstrates an opposing effect at rs62176107 (MNM p ¼ 1.08 3 10 À34 ; Table <ref type="table">S5</ref>); this variant is within exon 6 of PRKRA (MIM 603424) and also within microRNA 548n (MIR548N) and a noncoding transcript, AC009948.5.</s><s>PRKRA encodes protein kinase interferoninducible double-stranded RNA-dependent activator (PACT), a cellular dsRNA-binding protein originally identified as a binding partner and activator of PKR in response to extracellular stress. <ref type="bibr" target="#b48">46</ref></s><s>More recently, it has been shown to be an essential factor in the PKR-independent initiation (B) Comparative analysis of AD and psoriasis in which SNVs are color coded to show AD-specific effect (black), psoriasis-specific effect (red), shared effects defined as alleles operating in the same direction (green), and opposing effects (blue).</s><s>The genomewide significance level is marked at p ¼ 0.5 3 10 À8 (T max ¼ 6.0). of RIG-I-induced antiviral response. <ref type="bibr" target="#b49">47</ref></s><s>f note, individuals with AD are known to be susceptible to viral skin infections, but cutaneous infections rarely occur in psoriasis. <ref type="bibr" target="#b50">48</ref></s><s>icroRNAs play a role in posttranscriptional regulation of gene expression by affecting the stability and translation of mRNAs, but the specific role of miRNA548n has not been defined.</s><s>The most significantly associated (''lead'') SNV at 2q31.2 (rs62176107, G&gt;A, having the smallest p value from MNM) is a synonymous SNV with predicted effects on 12 transcripts, including PRKRA splice variants' UTR and intronic regions and a variant predicted to undergo nonsense-mediated decay (Ensembl release 75).</s><s>Gene expression profiling data show downregulation of both PRKRA mRNA and miRNA548n in psoriatic lesions compared to nonlesional skin, but no significant differences in AD (Table <ref type="table">S7</ref>).</s></p><p><s>The most highly significant variant at 5q33.1 (rs17728338) shows opposing effects on AD and psoriasis (MNM p ¼ 3.96 3 10 À38 ; Table <ref type="table">S5</ref>) and lies 2 kb upstream of ANXA6 (MIM 114070) and 8 kb downstream of TNIP1 (MIM 607714).</s><s>LD analysis in 1000 Genomes (release August 2009) via LocusZoom <ref type="bibr" target="#b51">49</ref> showed that rs17728338 is located within a 25-kb block containing both TNIP1 and ANXA6.</s><s>The locus has previously been associated with psoriasis in European and Chinese populations but has not been implicated in AD.</s><s>TNIP1 is involved in TNF signaling and regulation of the transcription factor NF-kB; <ref type="bibr" target="#b21">21,</ref><ref type="bibr" target="#b52">50</ref> it shows increased expression both in AD and psoriatic lesions compared to control skin (Table <ref type="table">S7</ref>).</s><s>In contrast, ANXA6, which encodes a calcium-dependent membrane and phospholipid binding protein, shows significant upregulation of expression in atopic skin compared to control skin (fold change 1.3, FDR p ¼ 0.016) and lesional to nonlesional AD skin (fold change 2.4, p ¼ 0.027), whereas expression is decreased in psoriatic versus healthy skin (fold change 0.7, p ¼ 6.38 3 10 À13 ) (Table <ref type="table">S7</ref>).</s><s>Clearly, further fine mapping is necessary to identify the causal variant that exerts opposing effects on AD and psoriasis, but we speculate that ANXA6 might be a switch-point differentiating AD from psoriasis that The American Journal of Human Genetics 96, 104-120, January 8, 2015 109</s></p><p><s>reflects the importance of calcium-dependent effects in keratinocyte differentiation.</s></p><p><s>Opposing effect loci were also identified within regions characterized by complex patterns of LD within the EDC (Figure <ref type="figure">S4</ref>), the cytokine cluster on 5q31.1 (Figures <ref type="figure">S4  and S5</ref>), and the MHC.</s><s>These regions were therefore investigated further via conditional analysis.</s></p><p><s>Stepwise Conditional Analysis within 1q21.3 and 5q31.1 Identifies Opposing and Disease-Specific Risk Variants Coverage of the EDC was achieved via GWAS data (Figure <ref type="figure">3</ref>), whereas ImmunoChip data provided better coverage for the cytokine cluster on 5q31.1 (Figures <ref type="figure">4  and S5</ref>).</s></p><p><s>Within 1q21.3 we identified seven LD blocks with disease-specific or opposing signals (Figure <ref type="figure">3A</ref>).</s><s>Stepwise conditional analysis on the four most prevalent FLGnull mutations and variants tagging the LCE3B-LCE3C deletion identified one AD-specific locus mapping to FLG, a psoriasis-specific locus mapping to LCE3B-LCE3C, and a locus with opposing effects on both diseases mapping to RPTN (MIM 613259)/HRNR/FLG-AS1 (Figure <ref type="figure">3B</ref> and Table <ref type="table" target="#tab_2">2</ref>).</s><s>After conditioning on the four FLG-null mutations and the LCE3B-LCE3C deletion, the G allele of the lead MNM SNV rs12130219 decreases the risk for AD (OR ADcond ¼ 0.812, p ADcond ¼ 0.0018) and increases the risk for psoriasis (OR PSOcond ¼ 1.119, p PSOcond ¼ 3.68 3 10 À4 ) (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Filaggrin, repetin, and hornerin are all members of the S100 fused-type protein family and each contribute to the cornified cell envelope, a functional component of the epidermal barrier.</s><s>Both FLG and HRNR show reduced expression in AD <ref type="bibr" target="#b53">[51]</ref><ref type="bibr" target="#b54">[52]</ref><ref type="bibr" target="#b55">[53]</ref> whereas RPTN shows no significant difference (Table <ref type="table">S7</ref>).</s><s>In psoriasis HRNR expression can be downregulated <ref type="bibr" target="#b55">53</ref> or upregulated, <ref type="bibr" target="#b56">54</ref> RPTN expression might be upregulated, and FLG expression might be downregulated <ref type="bibr" target="#b57">55</ref> or dysregulated <ref type="bibr" target="#b15">15</ref> (Table <ref type="table">S7</ref>).</s><s>The function of FLG-AS1 (FLG antisense RNA1) is currently undefined, but its proximity to FLG and HRNR suggests a role in coordinating keratinocyte terminal differentiation.</s><s>FLG-AS1 expression is increased in psoriasis lesional compared with nonlesional skin, whereas in AD lesional skin, expression is reduced (Table <ref type="table">S7</ref>).</s><s>Together, our results confirm the role of the LCE3B-LCE3C deletion in psoriasis and support the presence of genetic risk mechanisms for AD within the EDC in addition to the predominant effect of FLG-null mutations, with opposing effects on psoriasis.</s></p><p><s>Conditional analysis at 5q31.1 revealed three independent loci specifically contributing to AD risk: IL13 (MIM 147683, rs848, OR ADfull ¼ 1.12, p ¼ 0.0204), KIF3A (MIM 604683, rs 2299009, OR ADfull ¼ 1.16, p ¼ 4.1 3 10 À4 ), and SLC22A4 (MIM 604190)/C5orf56 (rs74458173, OR ADfull ¼ 1.57, p ¼ 2.0 3 10 À4 ) (Figure <ref type="figure">4A</ref>, Table <ref type="table" target="#tab_2">2</ref>).</s><s>None of these loci showed significant effects on psoriasis.</s><s>However, a fourth independent locus has opposing effects on AD and psoriasis.</s><s>The most highly significant variant maps  <ref type="figure">4B</ref>, Table <ref type="table" target="#tab_2">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of the MHC Confirms Multiple Psoriasis-Risk Loci and Identifies Opposing Effects</head><p><s>In the extended HLA region, we took forward 23,479 SNVs with T max &gt; 4.7 or BFDP &lt; 0.05 (PO ¼ 1/99) and 75 variables representing the classical HLA alleles obtained from HLA imputation for multinomial modeling, of which 18,515 SNVs were classified as specific to psoriasis by CCMA and MNM.</s><s>To reduce the data set for post hoc analysis, we considered only SNVs with effect classification in the same direction by CCMA and MNM, meeting the p &lt; 10 À5 threshold in MNM.</s><s>Within the psoriasis-specific markers, we excluded all tagging SNVs (r 2 &gt; 0.8 with the lead SNV), resulting in 1,503 SNVs, including those previously reported for AD. <ref type="bibr" target="#b20">20</ref></s><s>he strongest and most significant association was observed for psoriasis, a variant (rs111576655 OR PSOfull ¼ 3.32, p ¼ 3.2 3 10 À65 ) tagging the well-known psoriasisrisk allele HLA-C*06:02 (OR PSOfull ¼ 3.59, p ¼ 8.7 3 10 À154 ).</s><s>Conditional analysis revealed two additional independent loci contributing to psoriasis risk at MICA (MIM 600169, rs201374403, OR PSOfull ¼ 1.65, p ¼ 1.0 3 10 À26 ) and HLA-A (MIM 142800, rs113573479, OR PSOfull ¼ 1.41, p ¼ 2.7 3 10 À17 ), as well as two loci with opposing effects at HLA-C (MIM 142840, rs1793889, OR ADfull ¼ 0.6, OR PSOfull ¼ 1.18, p ¼ 1.1 3 10 À9 ) and HLA-DRB1 (MIM 142857, rs28383201, OR ADfull ¼ 0.61, OR PSOfull ¼ 1.18, p ¼ 6.5 3 10 À9 ) (Figure <ref type="figure">5</ref>, Table <ref type="table" target="#tab_3">3</ref>).</s><s>Conditional analysis with imputed classical alleles identified five independent HLAclass I alleles contributing to psoriasis risk in addition to HLA-C*06:02 and two alleles with opposing effects: HLA-C*03:03 (OR ADfull ¼ 0.71, OR PSOfull ¼ 1.27, p ¼ 2.3 3 10 À5 ) and HLA-DQA1*02:01 (OR ADfull ¼ 0.64, OR PSOfull ¼ 1.09, p ¼ 6.0 3 10 À8 ; r 2 ¼ 0.405 with rs28383201) (Table <ref type="table" target="#tab_3">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ontology and Network Analysis of Genes Indicate Effects in the Skin Barrier and Immune Response</head><p><s>Genes implicated from genome-wide and conditional analyses (identified from Tables 1, 2, and 3) were investigated via predicted protein network and gene ontology (GO) analysis.</s><s>The results are summarized in Figure <ref type="figure">S6</ref>.</s><s>The GO term ''keratinocyte differentiation'' (GO:0030216) is enriched in genes implicated in AD and psoriasis risk (FDR p ¼ 4.3 3 10 À4 in AD; p ¼ 6.9 3 10 À4 in psoriasis; and p ¼ 2.7 3 10 À3 in opposing effects).</s><s>The GO term ''response to interferon-gamma'' (GO:0034341) is also significantly enriched in psoriasis (FDR p ¼ 1.9 3 10 À3 ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>This genome-wide comparative analysis confirms a high degree of genomic coincidence between AD and psoriasis, suggesting that common molecular mechanisms are involved.</s><s>This agrees with the central role of epidermal barrier defects and T-cell-dominated inflammation in both diseases. <ref type="bibr" target="#b50">48</ref></s><s>Within the six regions of colocalization, we demonstrate coassociated and independent diseasespecific loci.</s><s>Of note, all coassociated loci display opposing (antagonistic) effects on AD and psoriasis, in agreement with the epidemiological observations of lower-thanexpected coincidence between these diseases in the population. <ref type="bibr" target="#b4">5</ref></s><s>Within these loci, specific variants including chromosome 2q31.2</s><s>(rs62176107), chromosome 5q33.1 (rs17728338), and within RAD50 on chromosome 5q33.3</s><s>(rs6596086) demonstrate opposing effects on risk of AD and psoriasis.</s><s>This raises the intriguing possibility that the same biological mechanisms might act differentially on AD versus psoriasis.</s><s>However, our current data cannot distinguish this specific opposing mechanism from the possibility that each lead variant is in LD with other variants having opposing effects in each disease.</s></p><p><s>The majority of the opposing effect loci are implicated in pathways related to adaptive immunological functions, which potentially mirrors the polarized immune mechanisms. <ref type="bibr" target="#b5">6</ref></s><s>It might further be speculated whether the presence of multiple opposing alleles reflects balancing selection as a response to heterogeneity in environmental pressures.</s><s>Balancing selection is particularly common within the extended MHC region and has been proposed as a potential explanation for antagonistic effects at multiple loci in different autoimmune diseases. <ref type="bibr" target="#b58">56</ref></s><s>wo of the loci displaying opposing effects (ANXA6/ TNIP1 and PRKRA) have not previously been reported in association with psoriasis and/or AD.</s><s>Formal external validation is limited by the requirement for additional independent, population-matched GWAS data for AD and psoriasis, but data available from RNA sequencing and microarray analyses provide some support for the differential expression of ANXA6/TNIP1 and PRKRA in AD and psoriasis, relative to normal or uninvolved skin.</s><s>The lead variant within PRKRA might mediate opposing effects in AD and psoriasis via miRNA processing and/or cellular response to environmental stress, and we hypothesize that this reflects the striking differential susceptibility to viral and bacterial skin infections observed in AD and psoriasis.</s><s>The opposing effect of variation in ANXA6 suggests a role for calcium-dependent effects in defining patterns of skin inflammation.</s></p><p><s>On chromosome 1q21.3,</s><s>apart from well-established AD-associated FLG mutations and psoriasis-associated with the lead SNV of each stepwise conditional analysis (defined as r 2 R 0.5).</s><s>Vertical lines are drawn to mark the positions of known genes and transcripts (identified from the UCSC Genome Browser GRCh37/hg19 accessed Feb. 2009), and horizontal dotted lines indicate significance thresholds of p ¼ 0.005, 10 À5 , and 10 À8 .</s><s>The horizontal gray bands at the bottom indicate the coverage of the region by GWAS SNVs (upper row) and ImmunoChip SNVs (lower row).</s><s>deletion of LCE3B-LCE3C, FLG-AS1 is a plausible candidate to mediate differential AD/psoriasis risk via the network of regulatory elements coordinating gene expression. <ref type="bibr" target="#b59">57</ref></s><s>Natural antisense transcripts contribute to gene regulation via a variety of transcriptional and posttranscriptional mechanisms <ref type="bibr" target="#b60">58</ref> and include effects on human epidermal differentiation. <ref type="bibr" target="#b61">59</ref></s><s>The proximity of FLG-AS1 to FLG and HRNR, combined with data showing coordinated differential expression of these genes, supports a role in control of keratinocyte terminal differentiation.</s></p><p><s>On chromosome 5q31.1,</s><s>antagonistic signals for AD and psoriasis have previously been attributed to IL13. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b21">21</ref></s><s>e here show that IL13 polymorphisms specifically influence AD risk, whereas opposing signals map to RAD50.</s><s>The Rad50 protein, a component of the MRN complex (Mre11, Rad50, and Nbs1), is involved in DNA double-strand break repair but has no known function directly related to AD or psoriasis.</s><s>However, RAD50 mRNA shows significantly increased expression in psoriasis lesional skin and a trend to reduced expression in AD lesional skin (Table <ref type="table">S7</ref>).</s><s>Of note, RAD50 is located in the center of the Th2-cytokine cluster and its 3 0 end is part of a locus control region regulating expression of these cytokine genes. <ref type="bibr" target="#b62">60</ref></s><s>AD and psoriasis represent opposing extremes of Th2 cell dysregulation, and therefore we hypothesize that RAD50 polymorphisms might exert opposing effects on AD and psoriasis through variation in DNA repair resulting in a differential skew in Th2 cell response.</s></p><p><s>Our dissection of the MHC locus confirms the presence of multiple independent psoriasis-risk loci.</s><s>Markers tagging HLA-Cw*0602 generate the strongest effects, which is in line with previous reports. <ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b21">21,</ref><ref type="bibr" target="#b25">24,</ref><ref type="bibr" target="#b46">44,</ref><ref type="bibr" target="#b63">61</ref></s><s>CD8 þ T cells are increased in the epidermis of lesional psoriatic skin, and the association of psoriasis susceptibility primarily with class I HLA alleles might reflect the critical role of psoriasis-associated (auto-)antigen presentation to pathogenic CD8 þ T cells. 62</s><s>CD8 þ T cells are also increased in the epidermis of AD skin, but with strikingly different cytokine profiles compared to psoriasis. <ref type="bibr" target="#b65">63</ref></s><s>The opposing effects of class II HLA alleles in AD and psoriasis might represent the differential responses to pathogenic and allergenic peptides presented to CD4 þ T cells. <ref type="bibr" target="#b66">64</ref></s><s>GWASs in AD by univariate and multivariate models have reported association signals in the MHC class I and II regions <ref type="bibr" target="#b23">22,</ref><ref type="bibr" target="#b67">65</ref> and two specific HLA class II haplotypes, HLA-DRB1*0701 (a protective effect) and HLA-B*4402 (a risk effect). <ref type="bibr" target="#b20">20</ref></s><s>Our analysis confirms the association of classical HLA class II alleles with AD, but in the conditional analysis, only HLA-DQA1* 02:01 remained, showing a significant protective effect on AD and a significant opposing effect on psoriasis.</s><s>A further opposing locus mapped to HLA-C*03:03 (Table <ref type="table" target="#tab_3">3</ref>).</s></p><p><s>The reported observation of AD occurring within the offspring of parents with psoriasis 8 is not supported by our findings, and the observation that both Th1-cell-dominated autoimmune and Th2-cell-dominated allergic diseases can show aggregation within families 7 also presents a discrepancy with our analyses.</s><s>It is possible that there are shared risk loci for AD and psoriasis that were not detected in our current study because of lack of power, if the shared effect is not strong; alternatively, there might be hereditary risk factors associated with predisposition to any chronic inflammatory (auto-)immune disease.</s><s>It is also possible that diagnostic misclassification occurs, particularly in pediatric cases, where the clinical signs of psoriasis are more difficult to distinguish from AD than is the case in adult disease, <ref type="bibr" target="#b68">66</ref> or by recall bias for disease in parents.</s></p><p><s>It is interesting to estimate the extent to which our findings can explain the mutual exclusivity of AD and psoriasis, but an accurate assessment is hindered by the lack of published data on the proportion of AD and psoriasis cases where the diseases do and do not co-occur.</s><s>Henseler et al. report a 25-fold lower prevalence of AD occurring in psoriasis cases <ref type="bibr" target="#b4">5</ref> and assuming a prevalence of 10% and 2% for AD and psoriasis, respectively, <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> we estimate that the effects at the six opposing loci listed in Tables <ref type="table" target="#tab_2">1, 2</ref>, and 3 would result in a reduction in prevalence of AD from 10% to 8% within the group of individuals with psoriasis.</s><s>This 2% reduction contrasts with the 25-fold reduction reported by Henseler et al., <ref type="bibr" target="#b4">5</ref> which is equivalent to a reduction of 9.6%, from 10% in the population to 0.4%.</s><s>Our results have therefore explained approximately 21% (2/9.6 3 100) of the mutual exclusivity of AD and psoriasis.</s></p><p><s>Taken together, our comparative analyses of AD and psoriasis support a paradigm in which genetic factors determining keratinocyte differentiation and cutaneous barrier function have particularly strong effects on AD risk, whereas in psoriasis genetic factors influencing (auto-)antigen recognition are of paramount importance.</s><s>Furthermore, multiple pleiotropic loci with antagonistic effects contribute to opposing mechanisms of adaptive immunity in both AD and psoriasis.</s></p><p><s>The meta-analysis-inspired methodology developed in the course of this study has demonstrated the power to leverage additional information from GWAS and highdensity SNV data and to dissect cross-phenotype associations.</s><s>AD and psoriasis are particularly well suited to the compare/contrast approach, but this methodology will be associated with AD and psoriasis); black squares indicate the residual AD-specific association after conditioning on the lead SNVs in RAD50 and IL13 (genes reported to be associated with AD); and black triangles indicate the residual AD-specific association after additionally conditioning on the lead SNV in KIF3A (a gene reported to be associated with AD).</s><s>SNVs indicated by the same symbol are in LD with the lead SNV of each stepwise conditional analysis (defined as r 2 R 0.5).</s><s>Vertical gray shading marks the positions of known genes (identified from the UCSC Genome Browser GRCh37/hg19 accessed Feb. 2009), and horizontal dotted lines indicate significance thresholds of p ¼ 0.005, 10 À5 , and 10 À8 ; results are shown for SNVs in LD with the lead SNV (defined as r 2 R 0.5).</s><s>The horizontal bands at the bottom indicate the coverage of the region by GWAS SNVs (upper row) and ImmunoChip SNVs (lower row).</s><s>Stepwise conditional analysis at chr5q31.1 was carried out using multinomial regression models and resulted in three additional signals for AD; this table shows only independent loci (r 2 &lt; 0.5) and the SNV with the strongest association; the effect allele is underlined.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>À3 ): CCDC80 (MIM 608298)/CD200R1L at 3q13.2, CARD11 (MIM 607210) at 7p22.2, ZNF365 (MIM 607818) at 10q21.2, and BCAS1 (MIM 602968) at 20q13.2 in AD; CSMD1 (MIM 608397) at 8p23.2, SERPINB8 (MIM 601697) at 18q22.1, MAMSTR (MIM 610349)/RASIP1 (MIM 609623) at 19q13.33, and ZNF816A at 19q13.41 in psoriasis (Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Genome-wide Comparison of AD and Psoriasis (A) Mirrored Manhattan plots showing results of AD meta-GWAS (top) and psoriasis meta-GWAS (bottom).(B)</s><s>Comparative analysis of AD and psoriasis in which SNVs are color coded to show AD-specific effect (black), psoriasis-specific effect (red), shared effects defined as alleles operating in the same direction (green), and opposing effects (blue).</s><s>The genomewide significance level is marked at p ¼ 0.5 3 10 À8 (T max ¼ 6.0).</s></p></div></figDesc><graphic coords="5,247.31,35.89,131.80,127.93" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Loci Showing Genome-wide Significant Association with Either AD or Psoriasis Defined by All Three Methods of Comparative Analysis</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Estimated Odds Ratio (95% CI)</cell><cell></cell></row><row><cell></cell><cell>Reference SNV</cell><cell></cell><cell></cell><cell>Effect Observed</cell><cell></cell><cell></cell><cell>Previous Report(s) of Association at</cell></row><row><cell>Chr Band</cell><cell>Number(s)</cell><cell>Position (hg19)</cell><cell>Nearest Gene(s) or Transcript(s)</cell><cell>in GW Analyses</cell><cell>AD</cell><cell>Psoriasis</cell><cell>This Locus</cell></row><row><cell>1p31.3</cell><cell>rs77614545 (del)</cell><cell></cell><cell cols="2">retro-DNAJB6 and IL23R (MIM 607562) psoriasis</cell><cell cols="3">0.99 (0.92-1.07) 1.21 (1.15-1.28) psoriasis: 1p31.3 locus, IL28RA 21,24,40</cell></row><row><cell>1q21.3 a</cell><cell>rs55879323</cell><cell></cell><cell>within FLG-AS1</cell><cell>opposing</cell><cell cols="3">0.76 (0.70-0.82) 1.05 (1.00-1.12) AD and psoriasis: 1q21.3 locus, HRNR,</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>FLG; 41 FLG; 20,42 LCE3B, LCE3C, 18 LCE</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>gene cluster; 17 LCE3D 24</cell></row><row><cell></cell><cell>rs11205006,</cell><cell>152440176,</cell><cell>RP1-91G5.3, CRNN (MIM 611312),</cell><cell>AD</cell><cell>1.52 (1.41-1.64),</cell><cell>0.97 (0.92-1.03),</cell><cell>AD: 1q21.3 locus, HRNR, FLG; 41 FLG 20,42</cell></row><row><cell></cell><cell>rs12144049</cell><cell></cell><cell>LCE5A (MIM 612619)</cell><cell></cell><cell>1.53 (1.42-1.64)</cell><cell>0.98 (0.92-1.03)</cell><cell></cell></row><row><cell></cell><cell>rs471144</cell><cell></cell><cell>LCE5A (MIM 612619)</cell><cell>AD</cell><cell cols="3">1.54 (1.37-1.73) 1.03 (0.94-1.14) AD: 1q21.3 locus, HRNR, FLG; 41 FLG 20,42</cell></row><row><cell></cell><cell>rs10888499</cell><cell></cell><cell>LCE3E (MIM 612617)</cell><cell>AD</cell><cell cols="3">1.49 (1.38-1.61) 0.98 (0.93-1.04) AD: 1q21.3 locus, HRNR, FLG; 41 FLG 20,42</cell></row><row><cell></cell><cell>rs4112788</cell><cell></cell><cell>LCE3D (MIM 612616)</cell><cell>psoriasis</cell><cell cols="3">0.97 (0.90-1.05) 1.22 (1.15-1.28) psoriasis: LCE gene cluster; 17 LCE3D 24</cell></row><row><cell></cell><cell>rs1581803</cell><cell></cell><cell>LCE3A (MIM 612613)</cell><cell>psoriasis</cell><cell cols="3">0.97 (0.90-1.04) 1.22 (1.15-1.30) psoriasis: LCE gene cluster 17</cell></row><row><cell></cell><cell>rs77199844 (del)</cell><cell></cell><cell>LCE1E (MIM 612607)</cell><cell>[AD]</cell><cell cols="3">2.01 (1.72-2.35) 1.16 (1.01-1.33) AD: 1q21.3 locus, HRNR, FLG; 41 FLG 20,42</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>psoriasis: LCE gene cluster 17</cell></row><row><cell></cell><cell>rs4363385</cell><cell></cell><cell>SNORA31, SPRR3 (MIM 182271),</cell><cell>[opposing]</cell><cell cols="3">1.23 (1.15-1.32) 0.89 (0.85-0.94) AD: SPRR3 repeat number variant 43</cell></row><row><cell></cell><cell></cell><cell></cell><cell>SPRR1B (MIM 182266)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>2p16.1</cell><cell>rs35741374</cell><cell></cell><cell>within lincRNA AC010733.4</cell><cell>psoriasis</cell><cell cols="3">1.09 (1.01-1.63) 1.20 (1.15-1.27) psoriasis: REL; 24 NR 23</cell></row><row><cell>2q31.2</cell><cell>rs62176107</cell><cell></cell><cell>exonic PRKRA and within miRNA548n</cell><cell>opposing</cell><cell cols="3">0.55 (0.46-0.65) 1.42 (1.32-1.53) -</cell></row><row><cell></cell><cell></cell><cell></cell><cell>and AC009948.5</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>5q31.1 a</cell><cell>rs1295686</cell><cell></cell><cell>intronic IL13 (MIM 147683) and within</cell><cell>[opposing]</cell><cell cols="3">1.27 (1.17-1.38) 0.88 (0.82-0.94) AD and psoriasis: IL13; 21 KIF3A, IL13; 22</cell></row><row><cell></cell><cell></cell><cell></cell><cell>AC004041.2</cell><cell></cell><cell></cell><cell></cell><cell>KIF3A, IL4, IL13-RAD50; 10 multiple</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>effect locus RAD50/IL13; 20 C5orf56</cell></row><row><cell></cell><cell>rs6596086</cell><cell></cell><cell>intronic RAD50 (MIM 604040)</cell><cell>opposing</cell><cell cols="2">1.30 (1.20-1.41) 0.85 (0.8-0.91)</cell><cell>AD and psoriasis: IL13-RAD50; 10</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>multiple effect locus RAD50/IL13 20</cell></row><row><cell>5q33.1</cell><cell>rs17728338</cell><cell></cell><cell>ANXA6 (MIM 114070)</cell><cell>opposing</cell><cell cols="3">0.70 (0.59-0.84) 1.77 (1.61-1.95) psoriasis: TNIP1 21,42</cell></row><row><cell>5q33.3</cell><cell>rs10515778, rs7715173,</cell><cell>158658012, 158664631,</cell><cell>within CTB-11I22.1</cell><cell>psoriasis</cell><cell cols="3">1.07 (0.98-1.17) 1.29 (1.21-1.38) psoriasis: 5q33.3 locus, IL12B 17,21,24,44 ;</cell></row><row><cell></cell><cell>rs7719425 b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>AD: PTTG1 42</cell></row><row><cell></cell><cell>rs11135056,</cell><cell cols="2">158687281, 158694100 intronic UBLCP1 (MIM 609867)</cell><cell>psoriasis</cell><cell cols="2">0.97 (0.89-1.05) 1.45 (1.35-1.56)</cell><cell></cell></row><row><cell></cell><cell>rs4921442 b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>rs2546890</cell><cell></cell><cell>within AC008697.1</cell><cell>psoriasis</cell><cell cols="2">1.01 (0.94-1.06) 1.39 (1.32-1.47)</cell><cell></cell></row><row><cell></cell><cell>rs5872599 (indel)</cell><cell></cell><cell>lincRNA AC008703.1, IL12B</cell><cell>psoriasis</cell><cell cols="2">0.82 (0.73-0.93) 1.54 (1.45-1.64)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>(MIM 161561)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>6q21</cell><cell>rs9487605</cell><cell></cell><cell>intronic KIAA1919</cell><cell>psoriasis</cell><cell cols="3">1.06 (0.98-1.14) 1.27 (1.20-1.35) -</cell></row><row><cell></cell><cell>rs240993</cell><cell></cell><cell>intronic REV3L (MIM 602776)</cell><cell>psoriasis</cell><cell cols="3">1.05 (0.97-1.13) 1.29 (1.22-1.36) -</cell></row><row><cell></cell><cell>rs9481169</cell><cell></cell><cell>TRAF3IP2 (MIM 607043)</cell><cell>psoriasis</cell><cell cols="3">0.98 (0.86-1.11) 1.58 (1.45-1.72) psoriasis and psoriatic arthritis:</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>TRAF3IP2 24,44,45</cell></row></table><note><p><s>(Continued on next page)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>5q31.1 were further investigated via stepwise conditional analysis (the results are shown in Table2); square brackets indicate results from the univariate analysis that were subsequently accounted for by other nearby variants when examined by stepwise conditional analysis.Figure 3. Regional Association within the Epidermal Differentiation Complex at 1q21.3 (A) Multinomial regression model with GWAS and ImmunoChip data.Seven blocks of linkage disequilibrium are indicated by curly brackets; black circles indicate AD-specific association, red circles indicate a psoriasis-specific association, blue circles represent opposing effects in AD and psoriasis, and green circles indicate shared effects.Vertical lines have been drawn to mark the positions of known genes and transcripts (identified from UCSC Genome Browser, GRCh37/hg19 accessed Feb. 2009) and the horizontal dotted lines indicate thresholds of suggestive and genome-wide significance (p ¼ 10À5and 10 MIM 604040, rs6596086, OR ADfull ¼ 1.17, OR P-SOfull ¼ 0.88, p ¼ 6.3 3 10 À7 ); this variant is associated with increased risk of AD but is protective against psoriasis (Figure</s></p></div></figDesc><table><row><cell>Continued</cell><cell>Estimated Odds Ratio (95% CI)</cell><cell>Reference SNV Effect Observed Previous Report(s) of Association at</cell><cell>Chr Band Number(s) Position (hg19) Nearest Gene(s) or Transcript(s) in GW Analyses This Locus AD Psoriasis</cell><cell>6q23.2 rs643177, rs582757 b 138195693, 138197824 TNFAIP3 (MIM 610669) psoriasis 1.05 (0.97-1.14) 1.27 (1.20-1.34) psoriasis: TNFAIP3 21,24</cell><cell>11q13.5 rs2212434, rs7126418 b 76281593, 76292573 c11orf30 (MIM 608574) AD 1.29 (1.21-1.39) 1.05 (1.00-1.11) AD: c11orf30-LRRC32; 10,41 c11orf30; 22</cell><cell>11q13 locus 20</cell><cell>12q13.3 rs36207871 (del) 56684496 intronic CS (MIM 118950) psoriasis 0.94 (0.83-1.06) 1.47 (1.33-1.67) psoriasis: 12q13.3 locus, IL23A,</cell><cell>STAT2; 21 IL23A 24</cell><cell>rs11575234 56744276 intronic STAT2 (MIM 600556) psoriasis 0.90 (0.79-1.02) 1.47 (1.32-1.64) psoriasis: STAT2 21</cell><cell>Genome-wide significance is defined as CCMA T max &gt; 6 and MANTRA BFDP &lt; 0.05 with PO ¼ 1/999 and multinomial model p &lt; 10 À8 ; genes and transcripts identified from UCSC Genome Browser Human Feb. 2009</cell><cell>(GRCh37/hg19) Assembly accessed 21 March 2014; this variant of FLG-AS1 extends across HRHR and FLG; RP1-91G5.3 extends across CRNN; AC004041.2 extends across RAD50 and IL13; CTB-11I22.1 overlaps RNF145.</cell></row></table><note><p><s>a 1q21.3 and b Multiple SNVs are assigned to the same LD block but odds ratios and 95% CI are presented only for the first SNV.</s><s>A B À8 ).</s><s>The horizontal gray bands at the bottom indicate the coverage of the region by GWAS SNVs (upper row) and ImmunoChip SNVs (lower row).</s><s>(B) Conditional regional association plot of stepwise logistic regression using GWAS and ImmunoChip data.</s><s>The different colored symbols indicate association results after each step of analysis, as follows.</s><s>Unconditioned results are shown by black dots to indicate association with AD and red dots to indicate association with psoriasis; blue triangles and blue crosses represent results after conditioning on the known disease-associated variants, FLG in AD and LCE3B-LCE3C deletion in psoriasis; SNVs indicated by the same symbol are in LD (legend continued on next page) The American Journal of Human Genetics 96, 104-120, January 8, 2015 111 to RAD50 (</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Conditional Analysis of the 1q21.3 and 5q31.1 Regions Showing Disease-Specific and Opposing Risk Effects in AD and Psoriasis represents the overall opposing signal calculated using the T 12opposing statistic and derive the p value from the normal distribution.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>AD</cell><cell></cell><cell>Psoriasis</cell><cell></cell><cell></cell><cell></cell><cell>AD</cell><cell>Psoriasis</cell></row><row><cell>Data</cell><cell></cell><cell></cell><cell></cell><cell>Candidate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Source Effect</cell><cell>SNV</cell><cell>Pos (hg19) Allele</cell><cell>Genes</cell><cell cols="2">OR (95% CI) p</cell><cell cols="2">OR (95% CI) p</cell><cell>p overall</cell><cell>a</cell><cell cols="2">OR (95% CI) p</cell><cell>OR (95% CI) p</cell><cell>P overall</cell><cell>a</cell></row><row><cell cols="3">Chromosome 1q21.3</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Unconditioned Analysis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Conditional Analysis b</cell></row><row><cell cols="4">GWAS Opposing rs12130219 152162106 G/A</cell><cell>FLG-AS1/</cell><cell>0.66</cell><cell cols="2">1.1 3 10 À16 1.15</cell><cell>4.0 3 10 À6</cell><cell cols="3">1.2 3 10 À23 0.812</cell><cell>0.0018</cell><cell>1.119</cell><cell>3.68</cell><cell>2.4 3 10 À6</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>RPTN/HRNR</cell><cell>(0.60-0.73)</cell><cell></cell><cell>(1.09-1.224)</cell><cell></cell><cell></cell><cell></cell><cell>(0.71-0.93)</cell><cell>(1.05-1.19)</cell><cell>3 10 À4</cell></row><row><cell cols="2">GWAS AD</cell><cell cols="2">rs12144049 152440910 C/T</cell><cell>FLG</cell><cell>1.53</cell><cell cols="2">2.7 3 10 À30 0.98</cell><cell>0.4140</cell><cell cols="3">3.0 3 10 À30 -</cell><cell>-</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1.42-1.64)</cell><cell></cell><cell>(0.92-1.03)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">GWAS Psoriasis</cell><cell cols="2">rs1581803 c 152592281 G/T</cell><cell>LCE3B/</cell><cell>0.97</cell><cell>0.4396</cell><cell>1.22</cell><cell cols="4">1.5 3 10 À12 1.6 3 10 À12 -</cell><cell>-</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>LCE3D</cell><cell>(0.90-1.04)</cell><cell></cell><cell>(1.16-1.30)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">GWAS Opposing rs35722864 153040505 G/GA SPRR cluster 0.81</cell><cell cols="2">1.0 3 10 À7 1.129</cell><cell>2.1 3 10 À5</cell><cell cols="3">4.8 3 10 À13 0.851</cell><cell>0.0019</cell><cell>1.074</cell><cell>0.0211 1.3 3 10 À4</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.75-0.88)</cell><cell></cell><cell>(1.07-1.20)</cell><cell></cell><cell></cell><cell></cell><cell>(0.71-0.93)</cell><cell>(1.01-1.14)</cell></row><row><cell cols="3">Chromosome 5q31.1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Conditional Models d</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Full Model</cell></row><row><cell>Ichip</cell><cell cols="3">Opposing rs6596086 131952222 C/T</cell><cell>RAD50</cell><cell>1.31</cell><cell cols="2">1.7 3 10 À13 0.86</cell><cell>1.7 3 10 À5</cell><cell cols="3">5.7 3 10 À21 1.17</cell><cell>4.04 3 10 À4 0.88</cell><cell>0.0023 6.3 3 10 À7</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1.22-1.41)</cell><cell></cell><cell>(0.80-0.92)</cell><cell></cell><cell></cell><cell></cell><cell>(1.07-1.28)</cell><cell>(0.81-0.96)</cell></row><row><cell>Ichip</cell><cell>AD</cell><cell>rs848</cell><cell>131996500 A/C</cell><cell>IL13</cell><cell>1.20</cell><cell cols="2">5.6 3 10 À5 0.96</cell><cell>0.3375</cell><cell cols="3">4.14 3 10 À5 1.12</cell><cell>0.0197</cell><cell>0.96</cell><cell>0.3515 0.0204</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1.10-1.30)</cell><cell></cell><cell>(0.89-1.04)</cell><cell></cell><cell></cell><cell></cell><cell>(1.02-1.23)</cell><cell>(0.88-1.05)</cell></row><row><cell>Ichip</cell><cell>AD</cell><cell cols="2">rs2299009 132042813 G/T</cell><cell>IL4/KIF3A</cell><cell>1.14</cell><cell cols="2">7.9 3 10 À4 0.99</cell><cell>0.7392</cell><cell>0.0018</cell><cell></cell><cell>1.16</cell><cell>2.03 3 10 À4 0.99</cell><cell>0.6657 4.1 3 10 À4</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1.06-1.23)</cell><cell></cell><cell>(0.92-1.06)</cell><cell></cell><cell></cell><cell></cell><cell>(1.07-1.25)</cell><cell>(0.92-1.06)</cell></row><row><cell>Ichip</cell><cell>AD</cell><cell cols="2">rs74458173 131621731 A/C</cell><cell>SLC22A4</cell><cell>1.57</cell><cell cols="2">6.1 3 10 À5 1.02</cell><cell>0.8590</cell><cell cols="3">2.14 3 10 À4 1.57</cell><cell>5.71 3 10 À5 1.02</cell><cell>0.8683 2.0 3 10 À4</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1.26-1.96)</cell><cell></cell><cell>(0.80-1.30)</cell><cell></cell><cell></cell><cell></cell><cell>(1.26-1.96)</cell><cell>(0.80-1.30)</cell></row><row><cell cols="7">Full model incorporates the combined effects of independent SNVs identified by stepwise analyses.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">c rs1581803 tags the previously reported psoriasis SNV rs4112788 (r 2 ¼ 0.995).</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a p overall b Conditional analysis of chr1q21.3 was conditioned on FLG for AD and LCE3B/LCE3D for psoriasis.d</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Conditional Analysis of the MHC Region on 6p21-22 Showing Psoriasis-Specific and Opposing Risk Effects in AD and Psoriasis 10 À4 4.28 (3.98-4.61)2.9 3 10 À362 1.303 10 À368 0.97 (0.82-1.15) 0.7475 3.59 (3.26-3.95)2.1 3 10 À159 8.7 3 À154 .017/0.032 0.61 (0.46-0.80) 3.83 3 10 À4 1.63 (1.44-1.84)8.0 3 10 À15 5.8 3 10 À20 0.60 (0.42-0.85) 0.0039 1.58 (1.38-1.81)3.8 3 10 À11 1.1 3 À13 .025/0.038 0.66 (0.54-0.81) 9.71 3 10 À5 1.30 (1.13-1.49)2.5 3 10 À4 5.9 3 10 À8 0.71 (0.56-0.90) 0.0040 1.27 (1.10-1.47)0.00112.3 3 À5 GWAS opposing DQA1*02:01 0.186/0.055/0.0980.64(0.54-0.76)3.44 3 10 À7 1.09 (1.01-1.19)0.03856.0 3 10 À8 0.64 (0.54-0.76) 3.4 3 10 À7 1.09 (1.01-1.19)0.03856.0 3 À8Effect allele is underlined.Abbreviations are as follows: PSO, psoriasis; AD, atopic dermatitis.Table shows only independent loci (r 2 &lt; 0.5) and the SNV with the strongest association.Stepwise conditional analysis was carried out with multinomial regression models and resulted in three psoriasis-specific and two opposing signals.The American Journal of Human Genetics 96, 104-120, January8, 2015 117 Health), Ludwig-Maximilians-Universita ¨t, as part of LMUinnovativ.</s><s>The project received infrastructure support through DFG Clusters of Excellence ''Inflammation at Interfaces'' (grants EXC306 and EXC306/2) and the German Federal Ministry of Education and Research within the framework of e:Med research and funding concept (sysINFLAME, 01ZX1306A).</s><s>M.M.N. is a member of the Cluster of Excellence ''ImmunoSensation.''</s><s>The NCRC-ADC is supported by the National Children's Research Centre, Dublin.</s><s>We also acknowledge use of Trinity Biobank samples from the Irish Blood Transfusion Service.</s><s>This work was supported by the NIH (R01AR042742, R01AR050511, R01AR054966, R01AR062886-01, R01AR062382) and by the Babcock Memorial Trust.</s><s>J.T.E. is supported by the Ann Arbor Veterans Affairs Hospital.</s><s>The URLs for data presented herein are as follows: 1000 Genomes, http://browser.1000genomes.org</s><s>Ensembl Genome Browser, http://www.ensembl.org/index.html</s><s>Online Mendelian Inheritance in Man (OMIM), http://www.</s><s>omim.org/</s><s>PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/</s><s>R statistical software, http://www.r-project.org/</s><s>RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq</s><s>STRING 9.1, http://www.string-db.org/</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Conditional Models a</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Full Model</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>HLA Allele/</cell><cell>AD</cell><cell></cell><cell cols="2">Psoriasis</cell><cell></cell><cell></cell><cell></cell><cell>AD</cell><cell>Psoriasis</cell></row><row><cell>Data</cell><cell></cell><cell></cell><cell></cell><cell>Candidate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Source Effect</cell><cell>SNV</cell><cell cols="2">Pos (hg19) Allele</cell><cell>Genes</cell><cell cols="2">OR (95% CI) p</cell><cell cols="2">OR (95% CI) p</cell><cell></cell><cell>p overall</cell><cell></cell><cell cols="2">OR (95% CI) p</cell><cell>OR (95% CI) p</cell><cell>p overall</cell></row><row><cell>GWAS PSO</cell><cell cols="2">rs111576655 31242731</cell><cell>A/T</cell><cell>C*06:02</cell><cell>0.84</cell><cell>0.0053</cell><cell>4.41</cell><cell cols="5">3.1 3 10 À376 9.8 3 10 À380 1.12</cell><cell>0.5071</cell><cell>3.32</cell><cell>2.3 3 10 À69 3.2 10 À65</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.74-0.95)</cell><cell></cell><cell cols="2">(4.10-4.74)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">(0.81-1.54)</cell><cell>(2.90-3.81)</cell></row><row><cell>GWAS PSO</cell><cell cols="2">rs201374403 31383754</cell><cell cols="2">T/TAG MICA</cell><cell>0.78</cell><cell cols="2">6.4 3 10 À5 1.68</cell><cell cols="5">7.9 3 10 À48 2.2 3 10 À53 0.81</cell><cell>0.0174</cell><cell>1.65</cell><cell>1.8 3 10 À25 1.0 10 À26</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.7-0.88)</cell><cell></cell><cell cols="2">(1.56-1.8)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">(0.67-0.96)</cell><cell>(1.50-1.81)</cell></row><row><cell>GWAS PSO</cell><cell cols="2">rs113573479 29842444</cell><cell>A/G</cell><cell>HLA-A</cell><cell>0.89</cell><cell>0.0109</cell><cell>1.39</cell><cell cols="5">6.6 3 10 À25 1.0 3 10 À26 0.92</cell><cell>0.1948</cell><cell>1.41</cell><cell>2.8 3 10 À17 2.7 10 À17</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.81-0.97)</cell><cell></cell><cell cols="2">(1.30-1.49)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">(0.81-1.04)</cell><cell>(1.30-1.52)</cell></row><row><cell cols="3">GWAS opposing rs28383201 32574869</cell><cell>C/G</cell><cell cols="2">HLA-DRB1 0.59</cell><cell cols="2">4.6 3 10 À13 1.15</cell><cell cols="2">4.5 3 10 À4</cell><cell cols="3">3.3 3 10 À16 0.61</cell><cell>3.4 3 10 À10 1.18</cell><cell>1.0 3 10 À4 6.5 10 À14</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.51-0.68)</cell><cell></cell><cell cols="2">(1.06-1.24)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">(0.52-0.71)</cell><cell>(1.08-1.28)</cell></row><row><cell cols="2">GWAS opposing rs1793889</cell><cell>31222181</cell><cell>A/G</cell><cell>HLA-C</cell><cell>0.60</cell><cell cols="2">2.5 3 10 À7 1.18</cell><cell cols="2">0.0011</cell><cell cols="2">1.1 3 10 À9</cell><cell>0.60</cell><cell>2.5 3 10 À7 1.18</cell><cell>0.0011</cell><cell>1.1 10 À9</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(0.50-0.73)</cell><cell></cell><cell cols="2">(1.07-1.31)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">(0.50-0.73)</cell><cell>(1.07-1.31)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Conditional Models a</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Full Model</cell></row><row><cell></cell><cell></cell><cell>HLA Allele</cell><cell></cell><cell>AD</cell><cell></cell><cell>Psoriasis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>AD</cell><cell></cell><cell>Psoriasis</cell></row><row><cell>Data</cell><cell></cell><cell cols="2">Frequency in</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Source Effect</cell><cell>HLA Allele</cell><cell cols="2">Ps/AD/Controls</cell><cell>OR (95% CI)</cell><cell>p</cell><cell cols="2">OR (95% CI)</cell><cell>p</cell><cell>p overall</cell><cell></cell><cell cols="2">OR (95% CI)</cell><cell>p</cell><cell>OR (95% CI)</cell><cell>p</cell><cell>p overall</cell></row><row><cell cols="6">GWAS PSO 0.271/0.075/0.089 0.81 (0.71-0.91) 8.48 3 GWAS PSO C*06:02 A*02:01 0.28/0.227/0.239 0.95 (0.88-1.03) 0.1793</cell><cell cols="3">1.32 (1.24-1.40) 4.1 3 10 À20</cell><cell cols="5">1.1 3 10 À20 0.99 (0.90-1.08) 0.7739</cell><cell>1.32 (1.24-1.41) 1.8 3 10 À17 1.1 3 À16</cell></row><row><cell cols="6">GWAS PSO 0.13/0GWAS PSO B*57:01 C*12:03 0.048/0.044/0.038 0.87 (0.74-1.03) 0.1169</cell><cell cols="3">1.74 (1.54-2.00) 5.2 3 10 À18</cell><cell cols="5">3.5 3 10 À19 0.86 (0.72-1.04) 0.1295</cell><cell>1.85 (1.62-2.11) 7.5 3 10 À20 1.8 3 À20</cell></row><row><cell>GWAS PSO</cell><cell>B*27:05</cell><cell cols="4">0.032/0.02/0.025 0.80 (0.63-1.01) 0.0619</cell><cell cols="3">1.59 (1.37-1.86) 2.9 3 10 À9</cell><cell cols="5">3.2 3 10 À10 0.74 (0.55-1.00) 0.0499</cell><cell>1.50 (1.28-1.76) 7.3 3 10 À7</cell><cell>1.8 3 À7</cell></row><row><cell>GWAS PSO</cell><cell>A*01:01</cell><cell cols="4">0.221/0.154/0.166 1.03 (0.94-1.13) 0.5475</cell><cell cols="3">1.25 (1.17-1.35) 2.3 3 10 À10</cell><cell cols="2">1.7 3 10 À9</cell><cell cols="3">1.08 (0.96-1.21) 0.2013</cell><cell>1.23 (1.14-1.33) 6.8 3 10 À8</cell><cell>4.0 3 À7</cell></row><row><cell cols="2">GWAS opposing C*03:03</cell><cell>0.037/0</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The American Journal of Human Genetics 96, 104-120, January 8, 2015 107</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="108">The American Journal of Human Genetics 96, 104-120, January 8, 2015</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The American Journal of Human Genetics 96, 104-120, January 8, 2015 113</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The American Journal of Human Genetics 96, 104-120, January 8, 2015 115</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A B</head><p><s>(B) Conditional regional association plot of the EDC by multinomial regression of GWAS and ImmunoChip data.</s><s>Different symbols indicate association results after each step of analysis, as follows.</s><s>Unconditioned results are shown by blue circles representing opposing effects in AD and psoriasis; black dots show AD-specific association results after conditioning on the lead SNV in RAD50 (a gene reported to (legend continued on next page) be applicable to many other complex traits with overlapping and disease-specific phenotypic features.</s><s>Characterizing shared and opposing molecular mechanisms across complex phenotypes will expand our understanding of biology and disease and will have implications for treatment and drug discovery.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplemental Data</head><p><s>Supplemental Data include Supplemental Consortia Information, six figures, and seven tables and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.2014.12.004.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consortia</head><p><s>Membership of the PAGE (Population Architecture using Genomics and Epidemiology) consortium is as follows: Trilokraj Tejasvi, Johann E. Gudjonsson, John J. Voorhees, Jun Ding, Yanming Li, Hyun M. Kang, Goncalo R. Abecasis, Dafna D. Gladman, Fawnda J. Pellett, Vinod Chandran, Cheryl F. Rosen, Proton Rahman, Sulev Koks, Ku ¨lli Kingo, Tonu Esko, Andres Metspalu, Peter Gregersen, Andrew Henschel, Marin Aurand, Bruce Bebo, and Henry W. Lim.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We are grateful to the individuals who provided clinical data and DNA for research.</s><s>This study makes use of genome-wide analysis data generated by the Wellcome Trust Case-Control Consortium (WTCCC); a full list of investigators is available at http://www.</s><s>wtccc.org.uk.</s><s>Funding for the WTCCC was provided by Wellcome Trust awards 076113 and 085475.</s><s>This work was additionally supported by the Wellcome Trust through an Intermediate Clinical</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Nonallergic comorbidities of atopic eczema: an overview of systematic reviews</title>
		<author>
			<persName><forename type="first">S</forename><surname>Deckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kopkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="37" to="45" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Pathogenesis and clinical features of psoriasis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Barker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team</title>
		<author>
			<persName><forename type="first">R</forename><surname>Parisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Symmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Ashcroft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="377" to="385" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Global epidemiology of psoriasis: a systematic review of incidence and prevalence</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Deckers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Linssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mommers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Van Schayck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e39803</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Disease concomitance in psoriasis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Henseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Christophers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Acad. Dermatol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="982" to="986" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mutual antagonism of T cells causing psoriasis and atopic eczema</title>
		<author>
			<persName><forename type="first">S</forename><surname>Eyerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Onken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Franke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nasorri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pennino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grosber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pfab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Schmidt-Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mempel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="231" to="238" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Shared familial aggregation of susceptibility to autoimmune diseases</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hemminki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sundquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sundquist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="2845" to="2847" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Transgenerational occurrence of allergic disease and autoimmunity: general practice-based epidemiological research</title>
		<author>
			<persName><forename type="first">T</forename><surname>Maas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nieuwhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Passos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´</forename><surname>Landewe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Voncken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Knottnerus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Damoiseaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prim. Care Respir. J</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="14" to="21" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">O</forename><surname>Cookson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ubhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Walley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">I</forename><surname>Leaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Trembath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Moffatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Harper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="372" to="373" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Paternoster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Standl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramasamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bønnelykke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Duijts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Thyssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Albrecht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Genetics of Overweight Young Adults (GOYA) Consortium; EArly Genetics &amp; Lifecourse Epidemiology (EAGLE) Consortium</title>
				<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="187" to="192" />
		</imprint>
	</monogr>
	<note>Nat. Genet.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">High-density genotyping study identifies four new susceptibility loci for atopic dermatitis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Baurecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Esparza-Gordillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rodrı ´guez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Matanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Marenholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hu ¨bner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schaarschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Michel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="808" to="812" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Genetic Analysis of Psoriasis Consortium</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Capon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tejasvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gudjonsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Collaborative Association Study of Psoriasis (CASP)</title>
		<imprint/>
	</monogr>
	<note>Psoriasis Association Genetics Extension</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity</title>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1341" to="1348" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Irvine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Terron-Kwiatkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Goudie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sandilands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="441" to="446" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rodrı ´guez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Baurecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Herberich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wagenpfeil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Cordell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Irvine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page">e7</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients</title>
		<author>
			<persName><forename type="first">U</forename><surname>Hu ¨ffmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Traupe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Oji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lascorz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sta ¨nder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lohmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wendler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Burkhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1367" to="1370" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Filaggrin null alleles are not associated with psoriasis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Terron-Kwiatkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Trembath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Capon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Griffiths</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1878" to="1882" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Pu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="205" to="210" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis</title>
		<author>
			<persName><forename type="first">R</forename><surname>De Cid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Riveira-Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Zeeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Robarge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Dannhauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giardina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helms</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="211" to="215" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Bergboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Zeeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Irvine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giardina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Novelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Den Heijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Illig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Riveira-Munoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="2057" to="2061" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Willis-Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kamatani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Baurecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Morar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Edser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Street</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>O'regan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="4841" to="4856" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Duffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gudjonsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tejasvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Feng</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<publisher>Collaborative Association Study of Psoriasis</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways</title>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="199" to="204" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hirota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsunoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tomita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakashita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujieda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Doi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1222" to="1226" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Genome-wide association analysis identifies three psoriasis susceptibility loci</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tejasvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gudjonsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Eberlein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gieger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1000" to="1004" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2 (2010). A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1</title>
		<author>
			<persName><forename type="first">A</forename><surname>Strange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Capon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Weale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Band</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bellenguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Bergboer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="985" to="990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The U.K. Working Party&apos;s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Burney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Pembroke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Dermatol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="406" to="416" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">PopGen: populationbased recruitment of patients and controls for the analysis of complex genotype-phenotype relationships</title>
		<author>
			<persName><forename type="first">M</forename><surname>Krawczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nikolaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Von Eberstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Croucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>El Mokhtari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schreiber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Community Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="55" to="61" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Illig</surname></persName>
		</author>
		<author>
			<persName><surname>Monica/Kora Study</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gesundheitswesen</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S26" to="S30" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Weiland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Von Mutius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Duhme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fritzsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hu ¨sing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Renz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Leupold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Keil</forename></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Respir. J</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="862" to="870" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Identification of loci associated with schizophrenia by genome-wide association and follow-up</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>O'donovan</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Craddock</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Norton</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Williams</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Peirce</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Moskvina</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nikolov</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamshere</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carroll</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Georgieva</surname></persName>
			<affiliation>
				<orgName type="collaboration">Molecular Genetics of Schizophrenia Collaboration</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1053" to="1055" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">PLINK: a tool set for wholegenome association and population-based linkage analyses</title>
		<author>
			<persName><forename type="first">S</forename><surname>Purcell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Neale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Todd-Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Maller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sklar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>De Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Daly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Sham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="559" to="575" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A linear complexity phasing method for thousands of genomes</title>
		<author>
			<persName><forename type="first">O</forename><surname>Delaneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Zagury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="179" to="181" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A new multipoint method for genome-wide association studies by imputation of genotypes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Marchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcvean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="906" to="913" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Auton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Depristo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Durbin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Handsaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Marth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Mcvean</surname></persName>
		</author>
		<title level="m">Genomes Project Consortium</title>
				<imprint>
			<date type="published" when="1000">1000. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">An integrated map of genetic variation from 1,092 human genomes</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="56" to="65" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">HLA*IMP-an integrated framework for imputing classical HLA alleles from SNP genotypes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Dilthey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moutsianas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leslie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcvean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="968" to="972" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A statistical method for predicting classical HLA alleles from SNP data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leslie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcvean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="48" to="56" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bhattacharjee</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rajaraman</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Wheeler</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Melin</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hartge</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yeager</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chung</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Chanock</surname></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">Chatterjee</forename></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
			<affiliation>
				<orgName type="collaboration">GliomaScan Consortium</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="821" to="835" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Transethnic meta-analysis of genomewide association studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="809" to="822" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">METAL: fast and efficient meta-analysis of genomewide association scans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2190" to="2191" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Bayes factors for genome-wide association studies: comparison with P-values</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wakefield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="79" to="86" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Zaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Miner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Malloy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Pullinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e1000041</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">A common variant on chromosome 11q13 is associated with atopic dermatitis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Esparza-Gordillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weidinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fo ¨lster-Holst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauerfeind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ruschendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Patone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Marenholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kerscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="596" to="601" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">F</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schaarschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">B</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Foelster-Holst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="690" to="694" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Association screening in the Epidermal Differentiation Complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema</title>
		<author>
			<persName><forename type="first">I</forename><surname>Marenholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Esparza-Gordillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauerfeind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lee-Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ciechanowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kurek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Piskackova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Macek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="1644" to="1649" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Debrus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Raelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Belouchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fournier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Reinhard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="991" to="995" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis</title>
		<author>
			<persName><forename type="first">U</forename><surname>Hu ¨ffmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Uebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Ekici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bowes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giardina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Korendowych</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Juneblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Apel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="996" to="999" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">PACT, a stress-modulated cellular activator of interferoninduced double-stranded RNA-activated protein kinase</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Handy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Goldsmith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Patel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PKR. J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="37993" to="37998" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Lui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Siu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Au</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Host Microbe</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="299" to="309" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts</title>
		<author>
			<persName><forename type="first">E</forename><surname>Guttman-Yassky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Nograles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Krueger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1110" to="1118" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">LocusZoom: regional visualization of genome-wide association scan results</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pruim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Welch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Teslovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Chines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Gliedt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boehnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2336" to="2337" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Molecular dissection of psoriasis: integrating genetics and biology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Elder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gudjonsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tejasvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nair</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="1213" to="1226" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Hornerin is a component of the epidermal cornified cell envelopes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haftek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nachat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gardinal-Galera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hitomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Balica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jean-Decoster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1567" to="1576" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Guttman-Yassky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sua ´rez-Farin ˜as</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiricozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Nograles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fuentes-Duculan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cardinale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bowcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Krueger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="1235" to="1244" />
			<date type="published" when="2009">2009. e58</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hansmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Meyer-Hoffert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gla ¨ser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schro ¨der</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e5227</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Identification of human hornerin and its expression in regenerating and psoriatic skin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takaishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Makino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Morohashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Huh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="4696" to="4703" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">TNF-a downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-a antagonists to improve skin barrier</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Howell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guttman-Yassky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Gilleaudeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Cardinale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boguniewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Krueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Leung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="1272" to="1279" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baldassano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Q</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Imielinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kugathasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Annese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dubinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Rotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Russell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="2059" to="2067" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis</title>
		<author>
			<persName><forename type="first">C</forename><surname>De Guzman Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Conlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Deming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Sears</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Segre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1453" to="1460" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Regulatory roles of natural antisense transcripts</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Faghihi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wahlestedt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="637" to="643" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Control of somatic tissue differentiation by the long non-coding RNA TINCR</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kretz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Siprashvili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zehnder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Flockhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Groff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">493</biblScope>
			<biblScope unit="page" from="231" to="235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Hypersensitive site 7 of the TH2 locus control region is essential for expressing TH2 cytokine genes and for long-range intrachromosomal interactions</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Spilianakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Flavell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="42" to="48" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Capon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hayday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">O</forename><surname>Nestle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Weale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Trembath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Genetic Analysis of Psoriasis Consortium; I-chip for Psoriasis Consortium</title>
				<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="5185" to="5192" />
		</imprint>
	</monogr>
	<note>Wellcome Trust Case Control Consortium</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">CD8(þ) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-g</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gunderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Podolsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Glick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="955" to="963" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">CD8(þ) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-g, IL-13, IL-17, and IL-22</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Knol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Gent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Giovannone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Beijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Kupper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bruijnzeel-Koomen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="973" to="979" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Mangalam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Taneja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>David</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="513" to="518" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tejasvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pellett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bowcock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="162" to="172" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kapila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fischer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Australas. J. Dermatol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="98" to="105" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
